Literature DB >> 9448547

How Renoir coped with rheumatoid arthritis.

A Boonen1, J van de Rest, J Dequeker, S van der Linden.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9448547      PMCID： PMC2128020          DOI： 10.1136/bmj.315.7123.1704

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Painting and sculpturing with "broken" hands: the victory of Renoir.

Authors:  Francesco Tonelli
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

2.  Historical perspective on the etiology of rheumatoid arthritis.

Authors:  Pouya Entezami; David A Fox; Philip J Clapham; Kevin C Chung
Journal:  Hand Clin       Date:  2011-02       Impact factor: 1.907

3.  Art in Science: The Artist and The Disease: The Exemplary Cases of Renoir and Toulouse-Lautrec.

Authors:  Berardo Di Matteo; Vittorio Tarabella; Giuseppe Filardo; Piergiuseppe Tanzi; Elizaveta Kon; Francesco Iacono; Maurilio Marcacci
Journal:  Clin Orthop Relat Res       Date:  2017-08-07       Impact factor: 4.176

4.  ["Memories of my sick hands": life and medical history of the painter Alexej von Jawlensky].

Authors:  H Zeidler
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

Review 5.  [Rheumatology reflected in art].

Authors:  A G Aeschlimann; F A Aeschlimann; B A Michel
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

Review 6.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

7.  Impairment and disability: Renoir's adaptive coping strategies against rheumatoid arthritis.

Authors:  Evan Kowalski; Kevin C Chung
Journal:  Hand (N Y)       Date:  2012-12

8.  Death of Seurat.

Authors:  Setu K Vora
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

9.  Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis.

Authors:  Atsushi Ogata; Kazuhide Tanimura; Toyohiko Sugimoto; Hiroshi Inoue; Yukitomo Urata; Tsukasa Matsubara; Masakazu Kondo; Yukitaka Ueki; Mitsuhiro Iwahashi; Shigeto Tohma; Shuji Ohta; Yukihiko Saeki; Toshio Tanaka
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-03       Impact factor: 4.794
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.